Matrix metalloproteinase-9 contributes to choroidal neovascularization

American Journal of Pathology

Volumn 161, Issue 4, 2002, Pages 1247-1253

  Lambert, Vincent ^a   Munaut, Carine ^a   Jost, Maud ^a   Noèl, Agnës ^a   Werb, Zena ^b   Foidart, Jean Michel ^a   Rakic, Jean Marie ^c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GELATINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; INFLAMMATORY CELL; LASER COAGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBRETINAL NEOVASCULARIZATION; TISSUE SECTION; TRANSGENIC MOUSE;

EID: 0036791476     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64401-X     Document Type: Article

References (34)

1. Campochiaro PA: Retinal and choroidal neovascularization. J Cell Physiol 2000, 184:301-310
2. Schwesinger C, Yee C, Rohan RM, Joussen AM, Fernandez A, Meyer TN, Poulaki V, Ma JJK, Redmond TM, Liu S, Adamis AP, D'Amato RJ: Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 2001, 158:1161-1172
3. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364
4. Mandriota SJ, Pepper MS: Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 1997, 110:2293-2302
5. Weber B, Vogt G, Pruett RC, Stohr H, Felbor U: Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994, 8:352-356
6. Ruiz A, Brett P, Bok D: TIMP-3 is expressed in the human retinal pigment epithelium. Biochem Biophys Res Commun 1996, 226:467-74
7. Kamei M, Hollyfield JG: TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci 1999, 40:2367-2375
8. Lambert V, Munaut C, Noel A, Frankenne F, Baiou K, Gerard B, Carmeliet P, Defresne MP, Foidart J-M, Rakic J-M: Influence of plasminogen activator inhibitor type I on choroidal neovascularization. FASEB J 2001, 15:1021-1027
9. Pepper MS: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001, 21:1104-1117
10. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S: Reduced angiogenesis and tumor progression in gelatinase A-deficient mice Cancer Res 1998, 58:1048-1051
11. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2:737-744
12. Chang C, Werb D: The many faces of metalloproteases: cell growth, invasion, angiogenesis, and metastasis. Trends Cell Biol 2001, 11: S37-S43
13. Manes S, Llorente M, Lacalle RA, Gomez-Mouton C, Kremer L, Mira E, Martinez-AC: The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma ceils. J Biol Chem 1999, 274:6935-6945
14. Dong Z, Kumar R, Yang X, Fidler IJ: Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997, 88:801-810
15. Das A, McGuire PG, Eriqat C, Ober RR, DeJuan Jr E, Williams GA, McLamore A, Biswas J, Johnson DW: Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci 1999, 40:809-813
16. Kosano H, Okano T, Katsura Y, Noritake M, Kado S, Matsuoka T, Nishigori H: ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy. Life Sci 1999, 64:2307-2315
17. Jin M, Kashiwagi K, lizuka Y, Tanaka Y, Imai M, Tsukahara S: Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina 2001, 21:28-33
18. Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A: Matrix metalloproteinases and metalloproteinases inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998, 39:2194-2200
19. Munaut C, Salonurmi T, Kontusaari S, Reponen P, Morita T, Foidart JM, Tryggvason K: Murine matrix metalloproteinase 9 gene 5′-upstream region contains cis-acting elements for expression in osteoclasts and migrating keratinocytes in transgenic mice. J Biol Chem 1999, 27:5588-5596
20. Behringer RR, Crotty DA, Tennyson VM, Brinster RL, Palmiter RD, Wolgemuth DJ: Sequences 5′ of the homeobox of the Hox-1.4 gene direct tissue-specific expression of lacZ during mouse development. Development 1993, 117:823-833
21. Mohan R, Rinehart WB, Bargagna-Mohan P, Fini E: Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling. J Biol Chem 1998, 40:25903-25914
22. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z: MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422
23. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT: Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000, 106:55-62
24. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA: Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998, 153:1641-1646
25. Bohm M, Wieland I, Schutze K, Rubben H: Microbeam MOMENT: non-contact laser microdissection of membrane-mounted native tissue. Am J Pathol 1997, 151:63-67
26. Munaut C, Noel A, Weidle UH, Krell HW, Foidart JM: Modulation of the expression of interstitial and type-IV collagenases in coculture of HT1080 fibrosarcoma cells and fibroblasts. Invasion Metastasis 1995, 15:169-178
27. Fini ME, Parks WC, Rinehart WB, Girard MT, Matsubara M, Cook JR, West-Mays JA, Sadow PM, Burgeson RE, Jeffrey JJ, Raizman MB, Krueger RR, Zieske JD: Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol 1996, 149:1287-1302
28. Yamada E, Tobe T, Yamada H, Okamoto N, Zack DJ, Werb Z, Soloway PD, Campochiaro PA: TIMP-1 promotes VEGF-induced neovascularization in the retina. Histol Histopathol 2001, 16:87-97
29. Salzmann J, Limb GA, Khaw PT, Gregor ZJ, Webster L, Chignell AH, Charteris DG: Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 2000, 84:1091-1096
30. Majka S, McGuire P, Colombo S, Das A: The balance between proteinases and inhibitors in a murine model of proliferative retinopathy. Invest Ophthalmol Vis Sci 2001, 42:210-215
31. Coussens LM Tinkle CL, Hanahan D, Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490
32. Oh H, Takagi H, Suzuma K, Otani A, Ishida K, Matsumura M, Ogura Y, Honda Y: The potential angiogenic roles of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999, 40:1891-1898
33. Kvanta A, Shen W-Y, Sarman S, Seregard S, Steen B, Rakoczy E: Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res 2000, 21:684-690
34. Engsig MT, Chen Q-J, Vu TH, Pedersen A-C, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaissé J-M: Matrix Metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000, 151:879-889